Compare HFWA & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HFWA | ATEC |
|---|---|---|
| Founded | 1927 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 1997 | 2006 |
| Metric | HFWA | ATEC |
|---|---|---|
| Price | $27.78 | $8.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $30.50 | $22.00 |
| AVG Volume (30 Days) | 197.0K | ★ 3.3M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | ★ 58.06 | 15.04 |
| EPS | ★ 0.48 | N/A |
| Revenue | N/A | ★ $101,739,000.00 |
| Revenue This Year | $45.85 | $18.97 |
| Revenue Next Year | $7.83 | $16.70 |
| P/E Ratio | $57.54 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.32 | $6.82 |
| 52 Week High | $28.98 | $23.29 |
| Indicator | HFWA | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 42.49 |
| Support Level | $26.26 | $6.82 |
| Resistance Level | $28.26 | $8.42 |
| Average True Range (ATR) | 0.64 | 0.37 |
| MACD | 0.06 | 0.12 |
| Stochastic Oscillator | 91.76 | 52.61 |
Heritage Financial Corp is a bank holding company. The company, through its subsidiary, provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as non-interest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.